An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid

Journal of Mass Spectrometry : JMS
Gunnar BrinkmalmAnn Brinkmalm

Abstract

Amyloid precursor protein (APP) is the precursor protein to amyloid β (Aβ), the main constituent of senile plaques in Alzheimer's disease (AD). Endogenous Aβ peptides reflect the APP processing, and greater knowledge of different APP degradation pathways is important to understand the mechanism underlying AD pathology. When one analyzes longer Aβ peptides by low-energy collision-induced dissociation tandem mass spectrometry (MS/MS), mainly long b-fragments are observed, limiting the possibility to determine variations such as amino acid variants or post-translational modifications (PTMs) within the N-terminal half of the peptide. However, by using electron capture dissociation (ECD), we obtained a more comprehensive sequence coverage for several APP/Aβ peptide species, thus enabling a deeper characterization of possible variants and PTMs. Abnormal APP/Aβ processing has also been described in the lysosomal storage disease Niemann-Pick type C and the major large animal used for studying this disease is cat. By ECD MS/MS, a substitution of Asp7 → Glu in cat Aβ was identified. Further, sialylated core 1 like O-glycans at Tyr10, recently discovered in human Aβ (a previously unknown glycosylation type), were identified also in cat ce...Continue Reading

References

Jan 1, 1990·Acta Neuropathologica·A C LowenthalA de Lahunta
Jul 1, 1985·The Biochemical Journal·M A Aon, J A Curtino
Jul 11, 2002·The Journal of Biological Chemistry·William E Van NostrandFeng Xu
Dec 19, 2002·Molecular & Cellular Proteomics : MCP·N Leigh Anderson, Norman G Anderson
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mark S SpringerStephen J O'Brien
Jun 18, 2003·Molecular Genetics and Metabolism·Kyra L SomersMary Anna Thrall
Jun 9, 2004·Biochemical and Biophysical Research Communications·Yuko HorikoshiYasuji Matsuoka
Jul 6, 2004·Journal of the American Society for Mass Spectrometry·Steven M PatrieBiswarup Mukhopadhyay
Sep 25, 2004·Mass Spectrometry Reviews·Bogdan Bogdanov, Richard D Smith
Mar 15, 2005·Analytical Chemistry·Chunguang G Yang, Mark E Bier
Feb 16, 2006·Molecular & Cellular Proteomics : MCP·Boris MacekMatthias Mann
Aug 1, 2006·Lancet·Kaj BlennowHenrik Zetterberg
Oct 20, 2006·Neuroscience Letters·Erik PorteliusKaj Blennow
Aug 31, 2007·Proceedings of the National Academy of Sciences of the United States of America·Derek E WildmanMorris Goodman
Sep 29, 2007·Nature Methods·Nertila Siuti, Neil L Kelleher
Nov 21, 2007·The FEBS Journal·Fred W McLaffertyTadhg P Begley
Jan 9, 2008·Rapid Communications in Mass Spectrometry : RCM·Thomas J-C VincentCatherine M Lange
Mar 21, 2008·Journal of Proteome Research·Erik PorteliusJohan Gobom
Mar 21, 2008·Analytical Chemistry·Michael J RothNeil L Kelleher
Jul 22, 2008·Chemistry Central Journal·Peter R JungblutHartmut Schlüter
Oct 10, 2008·Analytical Chemistry·Craig D WengerNeil L Kelleher
Feb 21, 2009·Neuro-degenerative Diseases·Erik PorteliusKaj Blennow
Apr 11, 2009·Annals of Neurology·Randall J BatemanDavid M Holtzman
Jun 30, 2009·Experimental Neurology·Erik PorteliusAnnika Ohrfelt
Jul 17, 2009·Neurobiology of Aging·Erik PorteliusKaj Blennow
Jul 23, 2009·JAMA : the Journal of the American Medical Association·Niklas MattssonKaj Blennow
Sep 11, 2009·Chemistry Central Journal·Hartmut SchlüterPeter R Jungblut
Mar 5, 2010·Glycobiology·Kristof ZarschlerChristina Schäffer
Jun 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Adnan HalimJonas Nilsson
Jul 7, 2011·Current Pharmaceutical Design·Erik PorteliusHenrik Zetterberg
Oct 11, 2011·Nature Methods·Catharina SteentoftHenrik Clausen

❮ Previous
Next ❯

Citations

Nov 25, 2014·Molecular Neurodegeneration·Ann BrinkmalmAnnika Öhrfelt
Dec 15, 2015·Acta Neuropathologica Communications·James K ChambersHiroyuki Nakayama
Nov 28, 2013·The FEBS Journal·Sophia Schedin-WeissLars O Tjernberg
Jun 20, 2014·Proteomics. Clinical Applications·Federica Del Monte, Giulio Agnetti
Apr 8, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Jessica M Mc DonaldDominic M Walsh
Feb 11, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kina HöglundErik Portelius
Apr 2, 2013·Brain Research·Gunnar BrinkmalmMagdalena Nutu
Jan 27, 2015·Biochimica Et Biophysica Acta·Ann BrinkmalmHenrik Zetterberg
Jul 11, 2014·Biochimie·Magnus RogebergTormod Fladby
Mar 12, 2016·Journal of Alzheimer's Disease : JAD·Angela L JeffersonDandan Liu
Jun 22, 2016·Glycoconjugate Journal·Naoyuki TaniguchiAkiko Furuta
Jun 29, 2014·Molecular & Cellular Proteomics : MCP·Ann BrinkmalmAnnika Öhrfelt
Oct 17, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Kristin AugutisNiklas Mattsson
Jun 16, 2018·Biomarkers in Medicine·Nicholas J AshtonHenrik Zetterberg
Jan 17, 2019·Journal of Biochemistry·Naosuke Nakamura, Akira Kurosaka
Dec 12, 2012·Neuromolecular Medicine·Magdalena NutuKaj Blennow
Mar 14, 2014·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Naoki KanekoKoichi Tanaka
Jan 6, 2017·Journal of Biochemistry·Keiko Akasaka-ManyaTamao Endo
Apr 30, 2019·Brain : a Journal of Neurology·Gunnar BrinkmalmDominic M Walsh
Sep 1, 2012·Metabolic Brain Disease·Niklas MattssonErik Portelius
Nov 22, 2020·Biomolecules·Keiko Akasaka-Manya, Hiroshi Manya
Nov 30, 2020·Journal of Neurochemistry·Faisal Hayat NazirBruno Becker
Jun 5, 2020·Current Topics in Medicinal Chemistry·Md Sahab UddinGhulam M Ashraf
Jul 30, 2021·ACS Chemical Neuroscience·YashoNandini SinghMaré Cudic
Sep 3, 2021·Journal of Neurochemistry·Eleni GkanatsiouGunnar Brinkmalm
Sep 11, 2021·Biological Chemistry·Lukas BuschBernd Bufe
Nov 3, 2021·EMBO Molecular Medicine·Juan Lantero-RodriguezKaj Blennow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.